155 related articles for article (PubMed ID: 23874525)
61. Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis.
Feng YQ; Li YU; Xiao WD; Wang GX; Li YO
Genet Mol Res; 2015 Oct; 14(4):13391-402. PubMed ID: 26535654
[TBL] [Abstract][Full Text] [Related]
62. Association between GNB3 c.825C > T polymorphism and the risk of overweight and obesity: A meta-analysis.
Li HL; Zhang YJ; Chen XP; Luo JQ; Liu SY; Zhang ZL
Meta Gene; 2016 Sep; 9():18-25. PubMed ID: 27114919
[TBL] [Abstract][Full Text] [Related]
63. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
Li YL; Tian Z; Zhao L; Zhang CL
Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
[TBL] [Abstract][Full Text] [Related]
64. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
65. The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.
Yu Z; Liu Q; Huang C; Wu M; Li G
OMICS; 2013 Apr; 17(4):200-14. PubMed ID: 23574339
[TBL] [Abstract][Full Text] [Related]
66. Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.
Zhai K; Yang Y; Gao ZG; Ding J
Oncotarget; 2017 Jul; 8(27):44490-44497. PubMed ID: 28548958
[TBL] [Abstract][Full Text] [Related]
67. Genetic association between PSA-158G/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis.
Su XJ; Zeng XT; Fang C; Liu TZ; Wang XH
Oncotarget; 2017 May; 8(20):33953-33960. PubMed ID: 28430620
[TBL] [Abstract][Full Text] [Related]
68. The role of MDM4 SNP34091 A>C polymorphism in cancer: a meta-analysis on 19,328 patients and 51,058 controls.
Jin X; Zhao W; Zheng M; Zhou P; Niu T
Int J Biol Markers; 2017 Mar; 32(1):e62-e67. PubMed ID: 27646776
[TBL] [Abstract][Full Text] [Related]
69.
Wang Z; Geng PL
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):620-626. PubMed ID: 32072832
[No Abstract] [Full Text] [Related]
70. Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis and meta-regression.
Liu Q; Yang J; He H; Yu Y; Lyu J
Clin Rheumatol; 2018 Dec; 37(12):3229-3237. PubMed ID: 30328021
[TBL] [Abstract][Full Text] [Related]
71. MDM4 rs4245739 A > C polymorphism correlates with reduced overall cancer risk in a meta-analysis of 69477 subjects.
Xu C; Zhu J; Fu W; Liang Z; Song S; Zhao Y; Lyu L; Zhang A; He J; Duan P
Oncotarget; 2016 Nov; 7(44):71718-71726. PubMed ID: 27687591
[TBL] [Abstract][Full Text] [Related]
72. Matrix metalloproteinase-2 -1306 C>T gene polymorphism is associated with reduced risk of cancer: a meta-analysis.
Haque S; Akhter N; Lohani M; Ali A; Mandal RK
Asian Pac J Cancer Prev; 2015; 16(3):889-96. PubMed ID: 25735378
[TBL] [Abstract][Full Text] [Related]
73. The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies.
Teng Z; Wang L; Cai S; Yu P; Wang J; Gong J; Liu Y
PLoS One; 2013; 8(2):e55332. PubMed ID: 23437053
[TBL] [Abstract][Full Text] [Related]
74. A comprehensive meta-analysis of genetic associations between five key SNPs and colorectal cancer risk.
Hong Y; Wu G; Li W; Liu D; He K
Oncotarget; 2016 Nov; 7(45):73945-73959. PubMed ID: 27661122
[TBL] [Abstract][Full Text] [Related]
75. Association between the -607 C > A polymorphism in interleukin-18 gene promoter with gastrointestinal cancer risk: a meta-analysis.
Yao J; Li ZH; Li YX; Zhang R; Zhang DG; Xu ZL; Wang LS; Wang JY
Genet Mol Res; 2015 Dec; 14(4):16880-7. PubMed ID: 26681034
[TBL] [Abstract][Full Text] [Related]
76. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
Lv L; Wang P; Sun B; Chen G
Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558
[TBL] [Abstract][Full Text] [Related]
77. Prognostic value of peptidyl-prolyl cis-trans isomerase 1 (PIN1) in human malignant tumors.
Khoei SG; Mohammadi C; Mohammadi Y; Sameri S; Najafi R
Clin Transl Oncol; 2020 Jul; 22(7):1067-1077. PubMed ID: 31728832
[TBL] [Abstract][Full Text] [Related]
78. A preliminary identification of PIN1 SNP linkage in patients with coronary heart disease from Handan, China.
Wang JZ; Zhang YH; Bai J; Du WT; Zhang XY
Rev Port Cardiol (Engl Ed); 2021 Feb; 40(2):133-139. PubMed ID: 33358249
[TBL] [Abstract][Full Text] [Related]
79. The role of the master cancer regulator Pin1 in the development and treatment of cancer.
Stewart R; Sharma S; Wu T; Okuda S; Xie G; Zhou XZ; Shilton B; Lu KP
Front Cell Dev Biol; 2024; 12():1343938. PubMed ID: 38745861
[TBL] [Abstract][Full Text] [Related]
80. Causal relationship between Alzheimer's disease and prostate cancer: a bidirectional Mendelian randomization analysis.
Li R; Peng L; Deng D; Li G; Wu S
Front Endocrinol (Lausanne); 2024; 15():1354528. PubMed ID: 38544686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
